Chanrx Corp. moved a step closer to the goal line for lead candidate vanoxerine (GBR-12909), reporting Phase IIb data at the American Heart Association (AHA) 2013 Scientific Sessions suggesting the ...

Omaha, NE - The results of a recent study have shown a trend toward a lower rate of early atrial fibrillation (AF) recurrence at 24 hours after direct-current (DC) cardioversion in patients receiving ...